Docaravimab
Based on 1 Customer Validation
Docaravimab is an antibody, targeting ERA (Evelyn-Rockitniki-Abelseth) glycoprotein ectodomain epitope G-III. Docaravimab can be used in research of Rabies.
Para uso exclusivo en investigación. No vendemos a pacientes.
- Pureza: 99.27%
- No. CAS: 2247196-23-0
- Peso molecular:146.48 kDa
-
Almacenamiento:
Please store the product under the recommended conditions in the Certificate of Analysis.
Actividad biológica
Mouse IgG2b kappa
Rabies lyssavirus
ERA
Unconjugated
The product can be reconstituted/diluted with sterile PBS or saline.
-
IgG2b-kappa
ELISA, FACS, Functional assay
-
Immobilized human Rabies virus Glycoprotein G His Tag can bind Docaravimab. The EC50 for this effect is 12.13 ng/mL.
Chemical Information
-
No. CAS 2247196-23-0
-
Appearance Liquid
-
Peso molecular 146.48 kDa
-
Color Colorless to light yellow
-
SMILES
[Docaravimab]
-
Synonyms
62-71-3
-
Envío
Shipping with dry ice.
-
Formulation
Please refer to the lot-specific COA for specific buffer information.
-
Almacenamiento
Please store the product under the recommended conditions in the Certificate of Analysis.
Pureza y Documentación
-
Ficha de datos (255 KB)
-
SDS (251 KB)
- English - EN (251 KB)
- Français - FR (251 KB)
- Deutsch - DE (251 KB)
- Norwegian - NO (251 KB)
- Español - ES (251 KB)
- Swedish - SV (251 KB)
- Italian - IT (251 KB)
- Korean - KR (251 KB)
- Portuguese - PT (251 KB)
-
Inhibitory Antibodies User Guide (603 KB)
Referencias
Calculators
Concentration (start) × Volume (start) = Concentration (final) × Volume (final)